Cargando…
Effect of early use of AbobotulinumtoxinA after stroke on spasticity progression: Protocol for a randomised controlled pilot study in adult subjects with moderate to severe upper limb spasticity (ONTIME pilot)
INTRODUCTION: Approximately 15 million people suffer a stroke annually, up to 40% of which may develop spasticity, which can result in impaired limb function, pain and associated involuntary movements affecting motor control. Robust clinical data on spasticity progression, associated symptoms develo...
Autores principales: | Kong, Keng He, Balcaitiene, Jovita, Berard, Hugues, Maisonobe, Pascal, Goh, Khean Jin, Kumthornthip, Witsanu, Rosales, Raymond L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936745/ https://www.ncbi.nlm.nih.gov/pubmed/29740633 http://dx.doi.org/10.1016/j.conctc.2017.02.004 |
Ejemplares similares
-
Early AbobotulinumtoxinA (Dysport(®)) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study
por: Rosales, Raymond L, et al.
Publicado: (2018) -
Effects of repeated abobotulinumtoxinA injections in upper limb spasticity
por: Gracies, Jean‐Michel, et al.
Publicado: (2017) -
Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment
por: Wissel, Jörg, et al.
Publicado: (2020) -
Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Adult Upper Limb Spasticity
por: Dashtipour, Khashayar, et al.
Publicado: (2015) -
AbobotulinumtoxinA Doses in Upper and Lower Limb Spasticity: A Systematic Literature Review
por: Schnitzler, Alexis, et al.
Publicado: (2022)